-
1
The Effects of MicroRNAs on Cardiomyopathy in a Rat Model of Streptozotocin-induced Diabetes Mellitus
Published 2025-01-01Subjects: “…diabetic cardiomyopathy…”
Get full text
Article -
2
Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling
Published 2025-01-01Subjects: Get full text
Article -
3
The role of NF-κB in diabetic cardiomyopathy
Published 2024-12-01Subjects: “…diabetic cardiomyopathy…”
Get full text
Article -
4
Multi-omics mechanical analysis of gut microbiota, carboxylic acids, and cardiac gene expression interaction triggering diabetic cardiomyopathy
Published 2025-01-01Subjects: “…diabetic cardiomyopathy…”
Get full text
Article -
5
PEDF Overexpression Ameliorates Cardiac Lipotoxicity in Diabetic Cardiomyopathy via Regulation of Energy Metabolism
Published 2025-01-01Subjects: Get full text
Article -
6
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
Published 2025-01-01Subjects: “…diabetic cardiomyopathy…”
Get full text
Article -
7
Mechanism of mTOR/RILP-regulated autophagic flux in increased susceptibility to myocardial ischemia-reperfusion in diabetic mice
Published 2025-01-01Subjects: “…diabetic cardiomyopathy…”
Get full text
Article -
8
Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine
Published 2025-01-01Subjects: “…diabetic cardiomyopathy…”
Get full text
Article -
9
Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
Published 2024-12-01Subjects: “…diabetic cardiomyopathy…”
Get full text
Article -
10
Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis
Published 2025-02-01Subjects: Get full text
Article